Why the mounting number of coronavirus mutations portends a potentially troubling future

Print Friendly, PDF & Email
Credit: India Today
Credit: India Today

For most of 2020, the coronavirus that causes COVID-19 jumped from human to human, accumulating mutations at a steady rate of two per month—not especially impressive for a virus. These mutations have largely had little effect.

But recently, three distinct versions of the virus seem to have independently converged on some of the same mutations, despite being thousands of miles apart in the United Kingdom, South Africa, and Brazil.

A recent study suggests that viruses with the E484K mutation might be better at evading antibodies from the blood plasma of recovered COVID-19 patients. Some viruses with this mutation could become a little better at reinfecting people or even infecting vaccinated people.

Related article:  Here's a virus that CRISPR can't touch—it could help researchers gain better control of the gene-editing tool

This one mutation alone is unlikely to render immunity from previous infections or vaccines totally ineffective, though.

Scientists now wonder whether the variants in South Africa and Brazil are spreading precisely because they have this slight advantage in overcoming previous immunity.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

The coronavirus is in a constant arms race against our immune system. It will keep evolving. That means our vaccines may need to evolve with it. But the United States is sequencing only a tiny percentage of its COVID-19 cases.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists